Zoledronic Acid and Chemotherapy in Ewing Sarcoma

In this episode of SARC Talk Journal Club, our panel discusses the EURO EWING 2012 Phase III trial, evaluating whether adding zoledronic acid to consolidation chemotherapy could improve outcomes for patients with Ewing sarcoma and Ewing-like sarcomas.The panel reviews the study design, key findings, event-free and overall survival outcomes, and the implications of adding zoledronic acid to treatment. What can this trial teach us about translating promising preclinical findings into clinical practice?Join us for an expert discussion of this important Ewing sarcoma clinical trial and what the results mean for future sarcoma research and treatment.